NCT03654066View on ClinicalTrials.gov

Botox or Botox With Esophageal Dilation in Patients With Achalasia

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 13, 2019

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Achalasia
Interventions
DRUG

Botulinum toxin type A

Botox injection in the LES

DEVICE

Endoscope balloon dilator

Distal esophageal dilation

OTHER

Patient reported outcomes

Subjects will complete two patient reported outcome measures (Eckardt and MADS).

DIAGNOSTIC_TEST

Barium esophagram

Assess for radiologic severity of achalasia with barium column height measured 1 minute and 5 minutes after upright ingestion of barium

Trial Locations (1)

37232

Vanderbilt University Medical Center Endoscopy Laboratory, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER